Can a groundbreaking cancer therapy help people with multiple sclerosis?

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis.

For years prior, she’d had severe fatigue, which a neurologist initially suspected was caused by narcolepsy. When she was struck with bouts of vertigo and eventually temporary vision loss, the doctor determined the correct diagnosis.

Miller, now 46, of Fishers, Indiana, spent 15 years on two different medications that made her feel sick every time she got a new dose. Her vision has faded in and out over the years, and in 2021, the mother of two started walking with a cane.

“I used to work as a lawyer, but reading a book is not even an option anymore,” she said.

Then, last year, Miller enrolled in an early-stage clinical trial at the Cleveland Clinic for a cancer therapy that researchers across the world are hoping could halt MS.